Table 2 Demographic and clinical characteristics of the participants.

From: Neuroplastic effects of end-effector robotic gait training for hemiparetic stroke: a randomised controlled trial

 

E-RAGT (n = 14)

BWST (n = 14)

p

Sex (male/female)

11/3a

12/2

1.000*

Age

55 ± 12b

51 ± 10

0.430†

Height (cm)

170.29 ± 9.15

168.71 ± 7.71

0.627†

Weight (kg)

67.14 ± 9.62

67.43 ± 8.90

0.936†

Post-stroke time (mon)

6.14 ± 2.83

5.79 ± 2.67

0.734†

Type (haemorrhage/infarct)

6/8

5/9

1.000*

Paretic side (right/left)

6/8

10/4

0.252*

Brunnstrom recovery stage

3.36 ± 1.21

2.93 ± 1.07

0.332†

FAC

3.00 ± 0.00

3.00 ± 0.00

1.000†

BBS

44.21 ± 3.72

44.14 ± 4.99

0.966†

  1. E-RAGT, end-effector robot-assisted gait training, BWST bodyweight-supported treadmill training, FAC functional ambulation category, BBS Berg Balance Scale.
  2. *χ2 test, †t-test.
  3. aNumber, bMean ± standard deviation.
Back to article page